v3.26.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Cash flows from operating activities:          
Net income $ 247 $ 397 $ 438 $ 386  
(Loss) income from discontinued operations, net of tax (Note 21) (50) 133 13 263  
Income from continuing operations 297 264 425 123  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation     280 276  
Amortization 52 52 104 103  
Amortization of deferred debt issuance costs     4 5  
Restructuring expense, net of cash paid     (14) (9)  
Deferred income taxes     (32) 309  
Pension and other postretirement benefit expenses     10 11  
Loss from equity method investments, net of dividends received     34 29  
Loss on extinguishment of debt (44) 0 (39) 3  
Loss on sale of assets   (5) 1 (6)  
Share-based compensation     50 64  
Net gain on equity method transactions (3) (46) (3) (46) $ (33)
Changes in operating assets and liabilities:          
Accounts receivable, net     (314) (204)  
Inventories     (230) (108)  
Other assets     (204) (93)  
Accounts payable     144 163  
Accrued and other long-term liabilities     (136) (106)  
Other, net     9 19  
Pension contributions     (7) (2)  
Net cash provided by operating activities from continuing operations     82 531  
Net cash (used in) provided by operating activities from discontinued operations     (133) 252  
Net cash provided by operating activities     (51) 783  
Cash flows from investing activities:          
Capital expenditures     (278) (267)  
Proceeds from sale of property     2 2  
Proceeds from business divestitures, net of cash sold     0 4  
Proceeds from sale of technology investments     0 1  
Proceeds from the sale of equity method investment     0 164  
Cost of technology investments     0 (42)  
Acquisition of redeemable noncontrolling interest     (67) 0  
Settlement of derivatives     (3) 5  
Net cash used in investing activities from continuing operations     (346) (133)  
Net cash used in investing activities from discontinued operations     (66) (79)  
Net cash used in investing activities     (412) (212)  
Cash flows from financing activities:          
Net proceeds (repayments) under other short-term debt agreements     (5) (324)  
Repayment of term loans     0 (250)  
Repayment of senior notes     (2,054) 0  
Fees related to modification of debt agreements     0 5  
Dividend received from spin-off of Versigent     1,920 0  
Cash transferred to Versigent related to spin-off     (282) 0  
Repurchase of ordinary shares     (322) 0  
Taxes withheld and paid on employees' restricted share awards     (32) (17)  
Net cash used in financing activities from continuing operations     (775) (596)  
Net cash provided by (used in) financing activities from discontinued operations     150 (136)  
Net cash used in by financing activities     (625) (732)  
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash     (1) 36  
(Decrease) increase in cash, cash equivalents and restricted cash     (1,089) (125)  
Cash, cash equivalents and restricted cash at beginning of period     1,854 1,574 1,574
Cash, cash equivalents and restricted cash at end of period 765 1,449 765 1,449 $ 1,854
Cash, cash equivalents and restricted cash of discontinued operations 0 328 0 328  
Cash, cash equivalents and restricted cash of continuing operations $ 765 $ 1,121 765 1,121  
Supplemental non-cash investing activities:          
Capital expenditures included in accounts payable     $ 116 $ 122